Diclofenac Sodium Topical Solution
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Diclofenac Sodium Topical Solution is a solution of Diclofenac Sodium in a suitable vehicle. It contains NLT 90.0% and NMT 110.0% of the labeled amount of diclofenac sodium (C14H10Cl2NNaO2).
2 IDENTIFICATION
A. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
B. The UV spectrum of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
3.1 Procedure
Solution A: Phosphoric acid and water (0.62:1000)
Solution B: 1.86 g of monobasic sodium phosphate dihydrate in 1000 mL of water
Solution C: Solution A and Solution B (50:50)
Mobile phase: Methanol and Solution C (70:30)
Diluent: Methanol and water (70:30)
Standard stock solution: 0.6 mg/mL of USP Diclofenac Sodium RS prepared as follows. Transfer a quantity of USP Diclofenac Sodium RS to a suitable volumetric ask, add 20% of the ask volume of methanol, sonicate to dissolve, and dilute with Diluent to volume. Standard solution: 0.06 mg/mL of USP Diclofenac Sodium RS from Standard stock solution diluted with Diluent
Sample solution: Nominally 0.06 mg/mL of diclofenac sodium prepared as follows. Transfer a quantity of Topical Solution to a suitable volumetric ask, add 20% of the ask volume of methanol, sonicate for about 10 min, and dilute with Diluent to volume. Pass a portion of the solution through a suitable lter of 0.45-µm pore size.
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 254 nm. For Identication B, use a diode array detector in the range of 200–400 nm.
Column: 4.6-mm × 25-cm; 5-µm packing L7
Column temperature: 30°
Flow rate: 1 mL/min
Injection volume: 10 µL
Run time: NLT 2 times the retention time of diclofenac
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 2.0
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of diclofenac sodium (C14H10Cl2NNaO2) in the portion of Topical Solution taken:
Result = (ru/rs) × (Cs/Cu) × 100
ru = peak response of diclofenac from the Sample solution
rs = peak response of diclofenac from the Standard solution
Cs = concentration of USP Diclofenac Sodium RS in the Standard solution (mg/mL)
Cu = nominal concentration of diclofenac sodium in the Sample solution (mg/mL)
Acceptance criteria: 90.0%–110.0%
4 IMPURITIES
4.1 Organic Impurities
Solution A, Solution B, Solution C, and Diluent: Prepare as directed in the Assay.
Mobile phase A: Use Solution C.
Mobile phase B: Methanol and acetonitrile (90:10)
Mobile phase: See Table 1.
Table 1
Time (min) | Mobile Phase A (%) | Mobile Phase B (%) |
| 0 | 40 | 60 |
| 30 | 40 | 60 |
| 48 | 25 | 75 |
| 60 | 25 | 75 |
| 62 | 40 | 60 |
| 70 | 40 | 60 |
Standard stock solution: 0.3 mg/mL of USP Diclofenac Sodium RS prepared as follows. Transfer a quantity of USP Diclofenac Sodium RS to a suitable volumetric ask, add 20% of the ask volume of methanol, sonicate to dissolve, and dilute with Diluent to volume. Standard solution: 0.003 mg/mL of USP Diclofenac Sodium RS from Standard stock solution diluted with Diluent
Sensitivity solution: 0.3 µg/mL of USP Diclofenac Sodium RS in Diluent from Standard solution
Sample solution: Nominally 0.6 mg/mL of diclofenac sodium prepared as follows. Transfer a suitable quantity of the Topical Solution to a suitable volumetric ask, add 20% of the ask volume of methanol, and sonicate to disperse. Add 50% of the ask volume of Diluent, sonicate for about 15 min, and dilute with Diluent to volume. Pass a portion of the solution through a suitable lter of 0.45-µm pore size. Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 254 nm
Column: 4.6-mm × 25-cm; 5-µm packing L1
Column temperature: 45°
Flow rate: 1.2 mL/min
Injection volume: 20 µL
System suitability
Samples: Standard solution and Sensitivity solution
Suitability requirements
Relative standard deviation: NMT 5.0%, Standard solution
Signal-to-noise ratio: NLT 10, Sensitivity solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of each specied and any unspecied degradation product in the portion of Topical Solution taken:
Result = (ru/rs) × (Cs/Cu) × (1/F) × 100
ru = peak response of each specied or unspecied degradation product from the Sample solution
rs = peak response of diclofenac from the Standard solution
Cs = concentration of USP Diclofenac Sodium RS in the Standard solution (mg/mL)
Cu = nominal concentration of diclofenac sodium in the Sample solution (mg/mL)
F = relative response factor (see Table 2)
Acceptance criteria: See Table 2.
Table 2
| Name | Relative Retention Time | Relative Response Factor | Acceptance Criteria, NMT (%) |
| Diclofenac keto analog | 0.3 | 1.7 | 0.2 |
Diclofenac lactam (diclofenac related compound A) | 0.5 | 1.4 | 0.5 |
| Diclofenac | 1.0 | _ | _ |
Unidentied degradation product A | 2.2 | 1.3 | 0.2 |
Any unspecied degradation product | _ | 1.0 | 0.2 |
| Total degradation products | _ | _ | 1.0 |
a 2-[(2,6-Dichlorophenyl)amino]phenyl-2-oxoacetic acid.
b 1-(2,6-Dichlorophenyl)indolin-2-one.
5 SPECIFIC TESTS
5.1 Microbial Enumeration Tests 〈61〉 and Tests for Specified Microorganisms 〈62〉:
The total aerobic microbial count is NMT 102 cfu/mL, and the total combined yeasts and molds count is NMT 10 cfu/mL. It meets the requirements of the tests for absence of Staphylococcus aureus and Pseudomonas aeruginosa.
Delete the following:
5.2 pH 〈791〉: 8.0–10.0▲ (RB 1-Apr-2021)
6 ADDITIONAL REQUIREMENTS
6.1 Packaging and Storage:
Store at controlled room temperature.
6.2 USP Reference Standards 〈11〉
USP Diclofenac Sodium RS

